Your browser doesn't support javascript.
loading
Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction.
Fayol, Antoine; Wack, Maxime; Livrozet, Marine; Carves, Jean-Baptiste; Domengé, Orianne; Vermersch, Eva; Mirabel, Mariana; Karras, Alexandre; Le Guen, Julien; Blanchard, Anne; Azizi, Michel; Amar, Laurence; Bories, Marie-Cécile; Mousseaux, Elie; Carette, Claire; Puymirat, Etienne; Hagège, Albert; Jannot, Anne-Sophie; Hulot, Jean-Sébastien.
Affiliation
  • Fayol A; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Wack M; CIC1418 and DMU CARTE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
  • Livrozet M; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Inserm, Paris, France.
  • Carves JB; Departement d'Informatique Hospitalière, DMU PRIME, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
  • Domengé O; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Vermersch E; CIC1418 and DMU CARTE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
  • Mirabel M; CIC1418 and DMU CARTE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
  • Karras A; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Le Guen J; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Blanchard A; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Azizi M; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Amar L; Department of Nephrology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
  • Bories MC; Department of Geriatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
  • Mousseaux E; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Carette C; CIC1418 and DMU CARTE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
  • Puymirat E; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Hagège A; Hypertension Department and DMU CARTE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
  • Jannot AS; Université de Paris, INSERM, PARCC, Paris, F-75006, France.
  • Hulot JS; Hypertension Department and DMU CARTE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou, Paris, France.
ESC Heart Fail ; 9(1): 519-530, 2022 02.
Article in En | MEDLINE | ID: mdl-34841727
ABSTRACT

AIMS:

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome with various causes that may influence prognosis. METHODS AND

RESULTS:

We extracted the electronic medical records for 2180 consecutive patients hospitalized between 2016 and 2019 for decompensated heart failure. Using a text mining algorithm looking for a left ventricular ejection fraction ≥50% and plasma brain natriuretic peptide level >100 pg/mL, we identified 928 HFpEF patients. We screened for a prevailing cause of HFpEF according to European guidelines and found that 418 (45.0%) patients had secondary HFpEF due to either myocardial (n = 125, 13.5%) or loading condition abnormalities (n = 293, 31.5%), while the remaining 510 (55.0%) patients had idiopathic HFpEF. We assessed the association between the causes of HFpEF and survival collected up to 31 December 2020 using Cox proportional hazards analysis. Even though patients with idiopathic HFpEF were older, frequently female, and had frequent co-morbidities and a higher crude mortality rate compared with secondary HFpEF patients, their prognosis was similar after adjustment for age and sex. Unsupervised clustering analysis revealed three main phenogroups with different distribution of idiopathic vs. secondary HFpEF. The phenogroup with the highest proportion of idiopathic HFpEF (69%) had (i) an excess rate of non-cardiac co-morbidities including chronic obstructive pulmonary disease (31%) or obesity (41%) and (ii) a better prognosis compared with the two other phenogroups enriched with secondary HFpEF.

CONCLUSIONS:

Aetiological classification provides clinical and prognostic information and may be useful to better decipher the clinical heterogeneity of HFpEF.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: ESC Heart Fail Year: 2022 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: ESC Heart Fail Year: 2022 Document type: Article Affiliation country: Francia